Company history · MRK

Merck after earnings, guidance and news: what happened the previous times

Every earnings report, outlook change and other company event Regimic has recorded for Merck since 2022 (6 events), each with how the stock moved 1 and 5 sessions later and what happened the previous times. Past reactions, not a probability.

ShareShare on LinkedIn

In short

  • The last 5 times Merck announced an acquisition, the stock was higher 5 sessions later in 4 of them (median move +2.5%, range −2.7% to +3.3%).

Past reactions, not a probability.

Event history

Every event, newest first

“The previous times” are the earlier events of the same type at Merck, at least 60 days before, the latest 12. Counts and medians need at least three of them.

Acquisition

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Business Wire

How the stock moved this time

1 session +1.8% (vs S&P 500 +2.0%, vs sector (XLV) +1.4%) · 5 sessions +2.5% (vs S&P 500 +3.8%, vs sector (XLV) +1.9%)

What happened the previous times

1 session later

Past cases
4
Median move
+0.2%
Range
−0.8% to +0.8%Worst 21 Nov 2023 · best 14 Nov 2025
Times higher
2 of 4 (50%)

Average move +0.1% · vs S&P 500 −0.2% · vs sector (XLV) 0.0%

5 sessions later

Past cases
4
Median move
+2.5%
Range
−2.7% to +3.3%Worst 21 Nov 2023 · best 21 Nov 2022
Times higher
3 of 4 (75%)

Average move +1.4% · vs S&P 500 +1.6% · vs sector (XLV) +0.5%

Acquisition

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

Business Wire

How the stock moved this time

1 session +0.8% (vs S&P 500 −0.2%, vs sector (XLV) +1.0%) · 5 sessions +3.0% (vs S&P 500 +4.9%, vs sector (XLV) +3.5%)

What happened the previous times

1 session later

Past cases
3
Median move
−0.2%
Range
−0.8% to +0.6%Worst 21 Nov 2023 · best 21 Nov 2022
Times higher
1 of 3 (33%)

Average move −0.1% · vs S&P 500 −0.2% · vs sector (XLV) −0.3%

5 sessions later

Past cases
3
Median move
+2.0%
Range
−2.7% to +3.3%Worst 21 Nov 2023 · best 21 Nov 2022
Times higher
2 of 3 (67%)

Average move +0.9% · vs S&P 500 +0.5% · vs sector (XLV) −0.5%

Acquisition

Merck to Acquire EyeBio

Business Wire

How the stock moved this time

1 session −0.2% (vs S&P 500 −0.3%, vs sector (XLV) −0.3%) · 5 sessions +2.0% (vs S&P 500 +1.5%, vs sector (XLV) −0.6%)

What happened the previous times

Only 2 earlier events of this type: too few for counts or a median.

Acquisition

Merck to Acquire Caraway Therapeutics, Inc.

Business Wire

How the stock moved this time

1 session −0.8% (vs S&P 500 −0.8%, vs sector (XLV) −1.0%) · 5 sessions −2.7% (vs S&P 500 −3.1%, vs sector (XLV) −2.9%)

What happened the previous times

Only 1 earlier event of this type: too few for counts or a median.

Acquisition

Merck to Acquire Imago BioSciences, Inc.

Business Wire

How the stock moved this time

1 session +0.6% (vs S&P 500 +0.6%, vs sector (XLV) +0.3%) · 5 sessions +3.3% (vs S&P 500 +3.0%, vs sector (XLV) +1.9%)

What happened the previous times

No earlier event of this type for Merck in the record.

Today’s news, with what happened the previous times

Historical Analogs puts today’s company news and the next scheduled market events next to how the market reacted the previous times. Past reactions, not a probability.

See Historical Analogs →

FAQ

Common questions

What did Merck stock do after it announced an acquisition?

The last 5 times, it was higher 5 sessions later in 4 of them, with a median move of +2.5% and a range from −2.7% to +3.3%. That describes past reactions, not a probability.

How are the stock moves measured?

From the first U.S. session open after the news to the close 1 and 5 sessions later, in percent, without dividends or costs. Each move is also shown against the S&P 500 (SPY) and the company’s sector ETF over the same sessions.

Which events are included?

Earnings reports against analysts’ estimates, outlook changes, dividends and buybacks, deals, CEO changes, regulatory decisions, major contracts and new products: company news published on Regimic and verified earlier events. Reports of the same event a few days apart count once; analyst rating changes are not company events.

Does this say what Merck stock will do next time?

No. These are past reactions, not a probability: every event is different, and the next reaction can fall outside the past range.

Every company event Regimic published in Company News or verified (earnings calendar, confirmed sources). Events are only added; a wrong one (another company with the same name, or removed by hand) is never shown, and a measured reaction never changes. Reaction: from the first U.S. session open after the news to the close 1 and 5 sessions later, also against SPY and the company's sector ETF. Previous times: earlier events of the same type at the same company, at least 60 days before, the latest 12; counts, median, range and averages need at least three cases. Reports of the same type at the same company within 7 days (30 days for quarterly results) are one event, dated by the first. Past reactions, not a probability. Data updated 02 Nov 2026. For information only; not investment advice. Methodology